
    
      A randomized, double-blind, single-center, controlled and parallel-assigned study comparing
      the efficacy and safety of intravenous, intra-articular and combinational administration of
      tranexamic acid to reduce blood loss during total knee replacement. Subjects will be
      monitored for occurrence of any complications, particularly deep venous thrombosis and
      thromboembolism during the hospital stay and for 3 months postoperatively.
    
  